Bank of New York Mellon »

Definium Therape shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 753k 18.90

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)

View all positions for Bank of New York Mellon

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape